Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Kafri

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Advances in Cell and Gene Therapy|September 9, 2022
Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T CellsSung Hyun Lee, Yajing Hao, Tong Gui, et al.
Journal of Virology|May 4, 2007
Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivoChengwen Li, Matthew Hirsch, Aravind Asokan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2008
A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vectorMatthew Bayer, Boris Kantor, Adam Cockrell, et al.
Frontiers in Oncology|April 18, 2022
Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for CancerMohammad Fereydouni, Mona Motaghed, Elnaz Ahani, et al.
Pediatric Endocrinology Reviews : PER|August 6, 2016
Insights into the Pathogenesis and Treatment of Krabbe DiseaseErnesto Roque Bongarzone, Maria Luisa Escolar, Steven James Gray, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Transactivator and structurally optimized inducible lentiviral vectorsKarin Haack, Adam S Cockrell, Hong Ma, et al.
Scientific Reports|February 2, 2018
Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanismsSilke Becker, Haibo Wang, Aaron B Simmons, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2002
Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrowDao Pan, Roland Gunther, Weiming Duan, et al.
Gene Therapy|September 8, 2018
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilizationPeirong Hu, Yanmin Bi, Hong Ma, et al.
Human Gene Therapy|August 9, 2019
Gene Delivery to Human Limbal Stem Cells Using Viral VectorsLiujiang Song, Zhenwei Song, Nathaniel J Fry, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Advances in Cell and Gene Therapy|September 9, 2022
Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T CellsSung Hyun Lee, Yajing Hao, Tong Gui, et al.
Journal of Virology|May 4, 2007
Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivoChengwen Li, Matthew Hirsch, Aravind Asokan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2008
A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vectorMatthew Bayer, Boris Kantor, Adam Cockrell, et al.
Frontiers in Oncology|April 18, 2022
Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for CancerMohammad Fereydouni, Mona Motaghed, Elnaz Ahani, et al.
Pediatric Endocrinology Reviews : PER|August 6, 2016
Insights into the Pathogenesis and Treatment of Krabbe DiseaseErnesto Roque Bongarzone, Maria Luisa Escolar, Steven James Gray, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Transactivator and structurally optimized inducible lentiviral vectorsKarin Haack, Adam S Cockrell, Hong Ma, et al.
Scientific Reports|February 2, 2018
Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanismsSilke Becker, Haibo Wang, Aaron B Simmons, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2002
Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrowDao Pan, Roland Gunther, Weiming Duan, et al.
Gene Therapy|September 8, 2018
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilizationPeirong Hu, Yanmin Bi, Hong Ma, et al.
Human Gene Therapy|August 9, 2019
Gene Delivery to Human Limbal Stem Cells Using Viral VectorsLiujiang Song, Zhenwei Song, Nathaniel J Fry, et al.
Pageof 6